Paragon Associates & Paragon Associates Ii Joint Venture »

Diamedica Therapeutics shares owned by Paragon Associates & Paragon Associates Ii Joint Venture

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Paragon Associates & Paragon Associates Ii Joint Venture from 13F filings

Historical chart of Paragon Associates & Paragon Associates Ii Joint Venture investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Paragon Associates & Paragon Associates Ii Joint Venture consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Paragon Associates & Paragon Associates Ii Joint Venture

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 500k 2.84
2023-09-30 $1.2M 470k 2.58
2023-06-30 $1.4M 325k 4.32